Osimertinib benefit inEGFR-mutant NSCLC patients withT790M-mutation detected by circulating tumour DNA
| Autor: | Remon, J., Caramella, C., Jovelet, C., Lacroix, L., Lawson, A., Smalley, S., Howarth, K., Gale, D., Green, E., Plagnol, V., Rosenfeld, N., Planchard, D., Bluthgen, M.V., Gazzah, A., Pannet, C., Nicotra, C., Auclin, E., Soria, J.C., Besse, B. * |
|---|---|
| Zdroj: | In Annals of Oncology April 2017 28(4):784-790 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|